Exchange Listed FDS TRETF
13F holders, Q1 2026 (March 31)6holders −1
1new positions
1sold out
$59.42avg. 13F price*
At the end of Q1 2026, 6 institutions reported holding Exchange Listed FDS TR in their 13F filings, down 1 from Q4 2025. 1 opened new positions and 1 sold out. The largest holders were Prostatis Group LLC ($7.5M), UBS Group AG ($85K) and JPMorgan Chase & Co. ($18K).
- Company
- Exchange Listed FDS TR
- CUSIP
- 30151E798
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $18K |
| Exits | 1 | $262K |
All 13F filers, Q4 2025 → Q1 2026: 1,210 shares bought and 28,843 shares sold, net −27,633 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 6 holders
| Prostatis Group LLC | 1.91% | Reduce -16.4% | 125,700 | $7.5M |
| UBS Group AG | 0.00% | Add +172.2% | 1,429 | $85K |
| JPMorgan Chase & Co. | 0.00% | New | 306 | $18K |
| Steward Partners Investment Advisory, LLC | 0.00% | No change | 185 | $11K |
| Allworth Financial LP | 0.00% | No change | 74 | $4K |
| Morgan Stanley | 0.00% | No change | 1 | $90 |
"% of holder's portfolio" is EXCHANGE LISTED FDS TR's weight in each manager's 13F, not the share of Exchange Listed FDS TR the manager owns.